Kerbusch, T., Milligan, P. A., & Karlsson, M. O. (2004). Assessment of the relative in vivo potency of the hydroxylated metabolite of darifenacin in its ability to decrease salivary flow using pooled population pharmacokinetic–pharmacodynamic data. Blackwell Science Inc.
Chicago Style aipamenaKerbusch, Thomas, Peter A. Milligan, and Mats O. Karlsson. Assessment of the Relative in Vivo Potency of the Hydroxylated Metabolite of Darifenacin in Its Ability to Decrease Salivary Flow Using Pooled Population Pharmacokinetic–pharmacodynamic Data. Blackwell Science Inc, 2004.
MLA aipamenaKerbusch, Thomas, Peter A. Milligan, and Mats O. Karlsson. Assessment of the Relative in Vivo Potency of the Hydroxylated Metabolite of Darifenacin in Its Ability to Decrease Salivary Flow Using Pooled Population Pharmacokinetic–pharmacodynamic Data. Blackwell Science Inc, 2004.